And that’s a wrap for #iMig2025
We’re thrilled to announce that Perth, Western Australia will host #iMig2027 — our bid was successful!
Thank you to our bid team (Profs Jenette Creaney, Ken O’Byrne, Nick Pavlakis & Tom John) and to the iMig Board.
See you in Perth in 2027 🇦🇺✨
Fantastic moment at #iMig2025 — PhD student Jessica Boulter presented her work showing that personalised cancer vaccines may be feasible for mesothelioma. A major step toward new immunotherapy options.
#Mesothelioma #CancerResearch #Immunotherapy #CancerVaccines
Busy day for NCARD at #iMig2025 — multiple posters on biomarkers, immunotherapy, copper targeting, neoantigens and PD-L1 PET imaging.
If you’re here, come meet the team at the poster mixer and talk research + collaboration.
#Mesothelioma #LungCancer #CancerResearch
Great start to #iMig2025 in Philadelphia!
Our Director Prof Jenette Creaney spoke in two plenaries: “Around the World in 90 Minutes” and “The iMig Crystal Ball”.
Later today, Dr Kofi Stevens chairs “In vitro & in vivo models in mesothelioma.”
#Mesothelioma #CancerResearch
We’re here at #iMig2025!
Visit the NCARD booth to hear about our latest research in #Mesothelioma and #LungCancer, and explore opportunities to collaborate on advancing #AsbestosAwareness and #CancerResearch.
NCARD leads at #iMig2025! Prof Anna Nowak becomes President as the conference introduces innovative collaboration formats in Philadelphia this October.
Abstract deadline: May 21. Details in our latest article: ncard.org.au/ncard-at-imi... #MesotheliomaResearch #GlobalCollaboration
